Paride Schito

My activity as a clinical neurologist, board-certified since 2022, focuses on motor neuron diseases, particularly ALS, and encompasses diagnostic refinement, disease management, biomarker discovery and validation, genetic profiling, and deep phenotyping, with the aim of elucidating disease heterogeneity and underlying pathogenic mechanisms.